Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Cyclophosphamide × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Lymphoma, Large B-Cell, Diffuse 38 Multiple Myeloma 27 Lymphoma 25 Leukemia, Myeloid, Acute 25 Burkitt Lymphoma 25 Breast Neoplasms 24 Lymphoma, Follicular 23 Leukemia, Lymphocytic, Chronic, B-Cell 22 Neoplasms 21 Lymphoma, Non-Hodgkin 21 Lymphoma, B-Cell 16 Myelodysplastic Syndromes 15 Lymphoma, Mantle-Cell 15 Hematologic Neoplasms 15 Leukemia 14 Melanoma 13 Lymphoma, B-Cell, Marginal Zone 13 Triple Negative Breast Neoplasms 12 Recurrence 12 Ovarian Neoplasms 11 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11 Hodgkin Disease 11 Pancreatic Neoplasms 10 Neuroblastoma 10 Medulloblastoma 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Leukemia, Biphenotypic, Acute 9 Brain Neoplasms 9 Neoplasm Metastasis 8

Interventions

durvalumab 3 Fulvestrant 3 Cisplatin 3 Carboplatin 3 ribociclib 2 pembrolizumab 2 palbociclib 2 abemaciclib 2 Pemetrexed 2 Letrozole 2 Anastrozole 2 trametinib 1 taletrectinib 1 sotorasib 1 selpercatinib 1 relatlimab 1 pralsetinib 1 exemestane 1 elacestrant 1 darolutamide 1 dabrafenib 1 ceralasertib 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Sunitinib 1 STX-478 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 RAD1901 1 Pregnancy Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡